Regencell Bioscience Holdings Ltd (RGC)
5.21
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
5.21
0.00 (0.00%)
After-Hours: 20:00
Regencell Bioscience Holdings Total Liabilities (Quarterly): 0.6323M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.6323M |
| December 31, 2022 | 0.8738M |
| December 31, 2022 | 0.8738M |
| June 30, 2022 | 0.938M |
| December 31, 2021 | 1.364M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.364M |
| June 30, 2021 | 4.338M |
| December 31, 2020 | 3.585M |
| December 31, 2020 | 3.585M |
| June 30, 2020 | 3.165M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.6323M
Minimum
Jun 2023
4.338M
Maximum
Jun 2021
2.072M
Average
1.364M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Global Pharmatech Inc | -- |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.62M |
| Shareholders Equity (Quarterly) | 12.03M |